Circular Genomics to Unveil New Data Highlighting Circular RNAs as a Transformative New Class of Blood-Based Biomarkers for Alzheimer's Disease at CTAD 2025

Press releases

1 day ago

Circular Genomics Receives $250K Investment from the Alzheimer's Drug Discovery Foundation (ADDF) to Advance First-in-Class Circular RNA Blood-Based Biomarker Tests for the Early Detection of AD

Press releases

Jul 8

Circular Genomics Announces Formation of its Commercial Advisory Board with Veteran Industry Leaders

Press releases

Jun 18